杏林製薬の株価時系列
日付 | 始値 | 高値 | 安値 | 終値 | 前日比 | 騰落率 | 出来高 |
---|---|---|---|---|---|---|---|
2020/04/10 | 2,167 | 2,210 | 2,136 | 2,203 | +36 | +1.7% | 281,200 |
2020/04/09 | 2,175 | 2,180 | 2,121 | 2,167 | -19 | -0.9% | 404,700 |
2020/04/08 | 2,175 | 2,207 | 2,156 | 2,186 | -11 | -0.5% | 305,200 |
2020/04/07 | 2,232 | 2,259 | 2,161 | 2,197 | -22 | -1% | 389,200 |
2020/04/06 | 2,210 | 2,249 | 2,180 | 2,219 | -10 | -0.4% | 461,700 |
2020/04/03 | 2,238 | 2,290 | 2,206 | 2,229 | +1 | ±0% | 536,300 |
2020/04/02 | 2,152 | 2,256 | 2,150 | 2,228 | +47 | +2.2% | 593,300 |
2020/04/01 | 2,330 | 2,330 | 2,181 | 2,181 | -17 | -0.8% | 1,206,500 |
2020/03/31 | 2,230 | 2,355 | 2,171 | 2,198 | -1 | ±0% | 1,308,800 |
2020/03/30 | 2,093 | 2,200 | 2,080 | 2,199 | +40 | +1.9% | 670,900 |
2020/03/27 | 1,976 | 2,159 | 1,975 | 2,159 | +197 | +10% | 916,600 |
2020/03/26 | 1,905 | 1,986 | 1,853 | 1,962 | +17 | +0.9% | 709,200 |
2020/03/25 | 1,987 | 1,990 | 1,904 | 1,945 | +13 | +0.7% | 758,600 |
2020/03/24 | 1,982 | 1,982 | 1,864 | 1,932 | -54 | -2.7% | 763,900 |
2020/03/23 | 2,000 | 2,029 | 1,911 | 1,986 | -20 | -1% | 568,700 |
2020/03/19 | 2,025 | 2,040 | 1,966 | 2,006 | +33 | +1.7% | 799,600 |
2020/03/18 | 1,967 | 2,060 | 1,941 | 1,973 | +66 | +3.5% | 1,212,300 |
2020/03/17 | 1,780 | 1,913 | 1,733 | 1,907 | +70 | +3.8% | 817,000 |
2020/03/16 | 1,885 | 1,981 | 1,800 | 1,837 | +72 | +4.1% | 971,900 |
2020/03/13 | 1,650 | 1,799 | 1,630 | 1,765 | -75 | -4.1% | 981,800 |
2020/03/12 | 1,896 | 1,919 | 1,827 | 1,840 | -82 | -4.3% | 895,800 |
2020/03/11 | 1,993 | 2,010 | 1,917 | 1,922 | -84 | -4.2% | 1,039,500 |
2020/03/10 | 1,920 | 2,037 | 1,854 | 2,006 | -31 | -1.5% | 1,142,900 |
2020/03/09 | 2,081 | 2,108 | 2,006 | 2,037 | -104 | -4.9% | 1,049,300 |
2020/03/06 | 2,038 | 2,179 | 2,036 | 2,141 | +81 | +3.9% | 1,410,000 |
2020/03/05 | 2,130 | 2,139 | 2,040 | 2,060 | -71 | -3.3% | 1,108,700 |
2020/03/04 | 2,132 | 2,149 | 2,067 | 2,131 | -45 | -2.1% | 1,177,800 |
2020/03/03 | 2,258 | 2,259 | 2,143 | 2,176 | -45 | -2% | 1,395,200 |
2020/03/02 | 2,259 | 2,317 | 2,177 | 2,221 | +59 | +2.7% | 2,260,400 |
2020/02/28 | 2,435 | 2,435 | 2,137 | 2,162 | -355 | -14.1% | 4,154,600 |
2020/02/27 | 2,474 | 2,550 | 2,355 | 2,517 | +243 | +10.7% | 9,385,600 |
2020/02/26 | 2,167 | 2,361 | 2,073 | 2,274 | +207 | +10% | 3,259,900 |
2020/02/25 | 2,079 | 2,089 | 2,026 | 2,067 | -69 | -3.2% | 432,400 |
2020/02/21 | 2,127 | 2,160 | 2,120 | 2,136 | +7 | +0.3% | 175,200 |
2020/02/20 | 2,099 | 2,152 | 2,096 | 2,129 | +26 | +1.2% | 268,200 |
2020/02/19 | 2,138 | 2,141 | 2,082 | 2,103 | -38 | -1.8% | 443,600 |
2020/02/18 | 2,212 | 2,218 | 2,133 | 2,141 | -152 | -6.6% | 618,200 |
2020/02/17 | 2,357 | 2,387 | 2,278 | 2,293 | -24 | -1% | 822,700 |
2020/02/14 | 2,520 | 2,600 | 2,253 | 2,317 | +165 | +7.7% | 1,435,200 |
2020/02/13 | 2,240 | 2,240 | 2,137 | 2,152 | -2 | -0.1% | 414,900 |
2020/02/12 | 2,233 | 2,233 | 2,129 | 2,154 | -86 | -3.8% | 317,200 |
2020/02/10 | 2,240 | 2,248 | 2,206 | 2,240 | +15 | +0.7% | 224,300 |
2020/02/07 | 2,200 | 2,226 | 2,194 | 2,225 | +41 | +1.9% | 274,900 |
2020/02/06 | 2,160 | 2,193 | 2,153 | 2,184 | +59 | +2.8% | 326,700 |
2020/02/05 | 2,075 | 2,140 | 2,034 | 2,125 | +41 | +2% | 524,700 |
2020/02/04 | 2,021 | 2,089 | 2,020 | 2,084 | +63 | +3.1% | 389,200 |
2020/02/03 | 1,969 | 2,044 | 1,969 | 2,021 | +40 | +2% | 326,400 |
2020/01/31 | 1,999 | 2,009 | 1,980 | 1,981 | +6 | +0.3% | 207,800 |
2020/01/30 | 1,980 | 1,994 | 1,967 | 1,975 | -5 | -0.3% | 169,100 |
2020/01/29 | 1,992 | 1,992 | 1,958 | 1,980 | +4 | +0.2% | 113,300 |
1251~
1300
件表示中 / 3705件
類似銘柄と比較する
現在ご覧いただいている「杏林製薬」と類似性の高い銘柄をピックアップ。投資家が注目しているデータで比較できるようになっています。銘柄選びの参考情報としてご活用ください。
銘柄名 | 最低購入代金 | 売上高 成長率 |
経常 増益率 |
配当 利回り |
PER | PBR | 直近のチャート | 特色 |
---|---|---|---|---|---|---|---|---|
杏林製薬 | 146,000円 | -2.4% | -52.3% | 3.90% | 17.47倍 | 0.62倍 |
|
医薬中堅。柱のぜんそく薬、呼吸器アレルギー薬は下期に比重。消化器領域育成。後発品も |
ゼリア新薬 | 213,700円 | +3.1% | -6.5% | 2.25% | 9.92倍 | 1.05倍 |
|
製薬中堅。医療用は消化器系中心。滋養強壮剤「ヘパリーゼ」も柱。スイス企業買収で海外展開 |
持田薬 | 297,600円 | +5.1% | -7.0% | 2.69% | 19.54倍 | 0.81倍 |
|
医薬中堅。高脂血症薬、降圧薬など循環器系得意。婦人科系にも強み。消化器系育成。化粧品も |
栄研化 | 200,000円 | +4.1% | -3.1% | 2.90% | 17.54倍 | 1.53倍 |
|
臨床検査薬大手。便潜血検査試薬(FIT)はシェア7割。尿検査(ウロ)、遺伝子検査も育成 |
ネクセラファーマ | 81,800円 | +20.3% | - | 0.00% | 145.04倍 | 1.08倍 |
|
創薬ベンチャー老舗。買収で成長。英国の創薬事業に日本が柱の後期治験・製造販売事業加わる |
市場注目の銘柄
チャート関連のコラム